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Abstract Deimination of arginyl residue of myelin basic
protein (MBP) reduces cationicity of MBP and impedes the
normal myelin membrane assembly. Less ordered structure
of MBP is more susceptible to proteolytic attack that may
lead to the release of highly immunogenic deiminated
peptides into extracellular milieu. We have studied the
association of peptides 45–89 derived from citrullinated
MBP (C8 isomer) and phosphorylated MBP (C3 isomer)
with the myelin lipids in a model membrane system using
optical waveguide lightmode spectrometry. The analysis of
association/dissociation kinetics to planar lipids under
controlled hydrodynamic conditions has shown that MBP
45–89 peptide from citrullinated C8 isomer is less effec-
tively adsorbed on the lipid membrane, than peptide from
phosphorylated C3 isomer and packing densities for
phosphorylated 45–89 MBP peptide is higher than for
citrullinated forms. On the other hand, our results shown
that continuous (24 h) exposure of mixed oligodendrocyte/
microglial cells to peptides 45–89 from MBP-C8 induces
apoptosis via mitochondrial pathway. In addition, pep-
tides 45–89 stimulated the secretion of nitric oxide from
microglial cells via induction of iNOS and decreased the
level of the inhibitory protein IkB, indicating involvement
of the transcription factor NF-kB in these processes. Our
results suggest that some citrullinated peptides, initially
released from oligodendrocytes, might activate microglia,
which produces reactive nitrogen species and generates in
turn fatal feedbacks that kill oligodendrocytes.
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Introduction
Activated microglia is significant component of the brain
pathology during the chronic neuroinflammatory diseases.
Among many endogenous or exogenous factors that regu-
late microglial activation and the brain inflammation, sec-
retary products of neurons, oligodendrocytes and vascular
endothelium have been suggested to play a key role in the
regulatory processes [1]. Various proteases are released
from apoptotic nerve cells during neuroinflammation and
linked to pathologic conditions of the CNS, including
ischemia, multiple sclerosis, Alzheimer’s disease, and
malignant glioma [2]. In additions to extracellular matrix
macromolecules, these proteases can degrade myelin
sheath proteins that are important in the pathogenesis of
inflammatory demyelinating diseases.
The 18.5 kDa isoform of myelin basic protein (MBP) is
one of the principal constituents of the mammalian myelin
sheath and plays a structural role in maintaining myelin
stability. MBP exhibits charge microheterogeneity as a
result of post-translational modifications such as phos-
phorylation, deamidation, deimination, arginine methyla-
tion, and N-terminal acylation [3]. Alteration of MBP
cationicity may represent a regulatory mechanism for
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normal myelin assembly or a degradative mechanism in
demyelinating disorders. Deimination of arginyl residue by
the action of peptidylarginine deiminase (EC 7.5-3.15)
reduces cationicity of protein and generates citrulline, an
important irreversible modification of MBP [4]. Citrulli-
nated MBP is structurally less ordered and more suscepti-
ble to proteolytic attacks. The reduction in cationicity of
citrullinated MBP impedes the membrane assembly and
exposes an immunodominant epitope of the membrane-
bound protein to proteases [5].
Immune response to citrullinated peptides is influenced
by class II major histocompatibility complex antigen
(MHC class II), which is abundantly expressed in microglia
in various neuropathological conditions [6]. The cytokines,
increased during neuroinflammation can induce microglia
to express MHC-II [1] and accordingly to bind immuno-
genic peptides of MBP. This process may start a cascade of
events that includes several feedback loops, setting in
motion a self-sustaining cycle inflammatory interaction
between activated microglia, oligodendrocytes and
neurones.
Noncovalent, mainly electrostatic and hydrophobic,
interactions are responsible for the multilamellar structure
and stability of myelin. Myelin is enriched in acidic lipids,
like glycosphingolipids, galactosylceramide, and its sul-
fated derivatives and their contribution in the formation
and maintenance of myelin is significant [7]. Myelin lipids
and proteins (mainly MBP) work synergistically to provide
the adhesion, and excess or deficit of MBP or anionic lipids
cause destruction of myelin structure [8, 9]. Thus, inter-
action of various cationic isoforms of MBP and their
fragments with acidic lipids is important for electrostatic
interactions and stabilization of multilamellar structure.
Although the interaction of MBP and MBP related peptides
with artificial membrane systems has been studied inten-
sively [10, 11], the interaction and adhesion of MBP
fragments with myelin natural lipids are not known. We
hypothesized that deiminated i.e., citrullinated peptides of
MBP have a low adsorption potential to the myelin lipids,
they are rapidly released after myelin sheet breakdown and
further increase the secretion of proinflammatory sub-
stances from glial cells.
Here we isolated natural lipids from myelin and used for
the characterization of adsorption properties of citrullinated
and noncitrullinated forms of MBP 45–89 peptide. Because
the planar geometry seems to be a better approximation to
the low curvature of the myelin sheath than the small,
highly curved vesicles, we have used OWLS technique for
careful analysis of the association and dissociation kinetics.
The planar geometry makes it easy to analyse the data with
true heterogeneous kinetics, rather than the pseudohom-
ogenous approximation which was used for the experi-
ments with vesicles [5]. We have found that deiminated
isoforms has low adsorption properties and releases more
rapidly from myelin natural lipids than corresponding
phosphorylated MBP peptides. Besides, our results have
shown that the released citrullinated peptides increase the
inflammatory potential of microglial cells and could induce
damage of oligodendrocytes.
Materials and Methods
Preparation of MBP and MBP 45–89 Peptides
MBP was isolated and purified from bovine brain white
matter according to the method of Chou et al. [12] followed
by HPLC. Briefly, the acid-soluble material was dissolved
in urea-glycine buffer, pH 9.6 and applied on a CM-52
cellulose cation exchange column, equilibrated in urea-
glycine buffer, pH 10.5. Following application of the
sample, urea-glycine buffer (10.5) flow was continued until
the first big peak had completely eluted. This unbound
fraction is the least cationic isomer, i.e., MBP C8. The
charge isomers C-5, C4, C3, C2 and C-1 were eluted from
the column with a sodium chloride gradient (0–0.2 M) in
the glycine-urea buffer, pH 10.6. The most cationic, least
modified charge isomer was C-1. Further purification of
C-8 was achieved by HPLC on a C-18 reverse phase col-
umn (Nova Pak, Waters) using a trifluoroacetic acid
(0.05 %)-acetonitrile (0–60 %) solvent system [13]. For
the cathepsin D digestion 0.5–0.7 mg MBP was suspended
in 1 ml of 0.05 M ammonium acetate, pH 3.5. A solution
of cathepsin D (enzyme:substrate ratios was 1:100) was
added to the protein suspension and the mixture was
incubated at 37 C for 30 min. MBP 45–89 peptide from
citrullinated MBP was purified by HPLC as described by
Cao et al. [14].
Total Myelin Lipid Preparation
Density gradient-purified CNS myelin was extracted twice
in 10 volumes of chloroform–methanol 2:1 (vol/vol) and
centrifuged. The pellet of the preparation was re-extracted
twice with the same solvent mixture. The supernatant was
dried in a stream of nitrogen. Lipids were dissolved in
hexane–ethanol 9:1 (vol/vol) at a final concentration of
20 mg/ml [7].
Optical Waveguide Light Mode Spectroscopy (OWLS)
The membrane-coated waveguides were assembled into a
flow-through cuvette [5] and mounted in the measuring
head of an IOS-1 integrated optics scanner (Artificial
Sensing Instruments, Zu¨rich). The effective refractive
indices of the zeroth order TE and TM modes were
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continuously monitored during the following three con-
secutive stages: (1) buffer flow; (2) MBP solution flow
(over a range of bulk protein concentrations cb from 2 to
100 lg/cm-3); and (3) buffer flow. Flow was laminar at a
wall shear rate of 22.4 s-1, and controlled by a precision
syringe pusher. The temperature was 25.0 ± 0.2 C. The
effective refractive indices were converted into numbers
(m) of adsorbed MBP molecules (or total adsorbed mass
M = mm, where m is the mass of one molecule of MBP) per
unit area of membrane. Quantitative evaluation was per-
formed by the general equation for association–dissocia-
tion kinetics at the solid–liquid interface as described early
[15]. Since complete desorption would have required tens
or hundreds of hours, we characterized it by fitting the
empirical function v tð Þ ¼ v0  v1ð Þe  Kdt þ v1 to
the measured portion, where v0 is the value immediately
before starting desorption (at t = 0) and v? the ‘‘irre-
versible’’ residue, with v? and kd as the fitting parameters.
We then calculated the parameter of adhesion strength
D ¼ 1  v1=v0 as a measure of desorbability.
Membrane preparation
Dissolved myelin lipids were spread on a laboratory-built
Langmuir trough with which lipid bilayers were assembled
on smooth planar optical waveguides as described by
Ramsden [15]. The waveguides had the composition
Si0.62Ti0.38O2 and a surface roughness (determined using
atomic force microscopy) of less than 0.09 nm, and were
obtained from Artificial Sensing Instruments, Zu¨rich,
Switzerland (type 2400). These have a thin waveguiding
layer optimized for detecting changes in the transverse
electric (TE) and transverse magnetic (TM) guided modes
with the highest possible sensitivity. A layer of water ca.
2–3 nm thick between the waveguide and the lipid ensures
that the membrane has fluidity comparable to that of the
physiological state.
Cell Cultures
Primary mixed glial cell cultures containing astrocytes,
microglia and oligodendrocytes were prepared from whole
brains of 2-day-old Wistar rats. The initial mixture of
dissociated glial cells was seeded in 75 cm2 flasks (2–3
brains/flask) coated with poly-D-lysine. The cultures were
maintained in DMEM with 10 % fetal calf serum and
cultured for 48 h. This step provides a means of separating
adherent cells, such as microglia and astrocytes, from
nonadherent cells, such as oligodendrocytes. The nonad-
herent oligodendrocyte fraction was plated into poly-D-
lysine-coated 25 cm2 flasks. For isolation of microglial
cells, confluent cultures between days 12 and 14 were
agitated on a rotary shaker at 37 C at 220 rpm for 1 h. The
floating cells were collected and incubated in tissue culture
plates. After 1 h the cultures were washed. The adherent
cells were identified as microglia. The astrocytes, i.e., the
cells remaining adherent after the removal of microglia,
were removed from the flasks by incubation with 0.25 %
trypsin, for 10 min.
Incubation of Cells with MBP 45–89 Citrullinated
Peptide
Cells were incubated for 24 h in the absence and presence
of 0.5 lL MBP 45–89 citrullinated peptide in serum-free
DMEM, at 37 C in a humidified atmosphere of 95 % air/
5 % CO2.
Cytotoxicity Assays
To assess cell viability, a modified 3-(4,5-dimethylthiasol-
2yl)-2,5 diphenyltetrazolium bromide (MTT) assay, a
sensitive first indicator of oxidative damage, was carried
out as described by Liu et al. [16]. Briefly, 106 glial cells
were treated with 0.5 mg ml-1 MTT followed by incuba-
tion at 37 C for 2 h in a CO2 incubator. After brief cen-
trifugation, supernatants were carefully removed and the
formazan reaction product was dissolved in acidic isopro-
panol. The formazan product was quantified spectropho-
tometrically by its absorbance at 570 nm. Data are
presented as a percentage of the absorbance obtained in
untreated cultures, after subtraction of blank values
obtained by incubation of MTT in medium alone. Trypan
blue exclusion assays were carried out after incubation
(5 min before counting) of cells with 0.04 % trypan blue
(Sigma). Dead cells were stained blue. Three fields per
coverslip were counted for each experimental condition,
and between 100 and 200 cells were counted on average
per field.
Assay for NO
Synthesis of NO was determined by assaying the culture
supernatants for nitrite [17]. Briefly, 400 ll of culture
supernatant was allowed to react with 200 ll of Griess
reagent [18] and incubated at room temperature for 15 min.
The optical density of the assay samples was measured
spectrophotometrically at 548 nm. Fresh culture medium
served as the blank in all experiments.
Western Blot Analysis
Following 24 h of incubation in the presence or absence of
MBP 45–89 peptides (0.5 lL), cells were removed from
the dishes, washed with PBS and homogenised in ice-cold
lysis buffer containing 1 % v/v Nonidet P-40, 100 mM
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NaCl, 20 mM Tris (pH 7.4), 10 mM NaF, 1 mM sodium
orthovanadate, 1 mM phenylmethylsulfonyl chloride, 1 lg
ml-1 leupeptin, 1 lg ml-1 antipain, 1 lg ml-1 aprotinin
and 1 lg ml-1 pepstatin A. Lysates were incubated at 4 C
for 15 min followed by centrifugation at 13,000 g for
15 min. The supernatant was used to study cytochrome c,
iNOS and IkB by immune blotting. After electrophoresis, the
proteins were transferred onto a nitrocellulose membrane.
Membranes were treated with primary and horseradish per-
oxidase-conjugated secondary antibodies (Santa-Cruz Bio-
technology, USA). Immunoreactivity was detected by
enhanced chemiluminescence autoradiography (ECL kit;
Amersham, UK) in accordance with the manufacturer’s
instructions. The following primary antibodies (Santa-Cruz
Biotechnology, USA) were used: against IkB, against iNOS
and against cytochrome c. Protein concentrations were
determined using a BCA protein assay kit (Pierce).
Statistical Analysis
Data shown in this study are expressed as mean ± SEM.
Statistical significance was analyzed by one-way analysis
of variance (ANOVA) followed by Tukey test with the
significance level set at p \ 0.05.
Results
Adhesion Properties of 45–89 Peptides Isolated
from Citrullinated (C8) and Phosphorylated (C3) MBP
Isomers
Decreases of positive charge of MBP in the citrullinated
isomers affect the ability of the protein to interact with
lipid bilayer. Deimination of MBP alters the secondary and
tertiary structures of MBP, producing a more unfolded,
open conformation that increases its susceptibility to
extracellular proteases. However, MBP peptide 45–89,
which contains an immunodominant and encephalitogenic
epitopes in MBP, was shown to be more stable for further
degradation than other MBP peptides released by proteases
and accumulated in extracellular fluids [14].There are two
serine (Ser 54, Ser 56) and three arginine (Arg 49, Arg 54
and Arg 65) residues in the bovine MBP which are able to
undergo modifications among this sequence [19]. There-
fore, we examined the adhesion properties of peptide
45–89 isolated from citrullinated MBP (C8 isomer) and
compared it with peptide 45–89 isolated from phosphory-
lated MBP (C3 isomer). Figure 1 shows the representative
adsorption/desorption curves and the calculated associa-
tion/dissociation parameters are collected in Table 1.
Figure 1 shows two representative adsorption/desorp-
tion curves. For both modified forms of MBP peptides, the
amount adsorbed gradually approached a plateau, i.e., dM/
dt approaching zero, indicative of the jamming of the
surface by the binding of at most a protein monolayer to the
membrane. Parameter M?, which represents an amount of
adsorbed protein, shows that incorporation of 45–89 MBP
peptide from phosphorylated isoform into lipids is higher
(86 ± 9 ng/cm2), whereas M? for citrullinated 45–89
MBP peptide was equal only to 22 ± 8 ng/cm2. However,
parameter a, which represents an area occupied by one
molecule of peptide and describes the amount of peptide
packing in the lipid bilayer, is lower for phosphorylated
one. Area occupied per molecule (a) of phosphorylated
45–89 MBP peptide upon adsorption at the membrane is
only 17.5 nm2, whereas the same parameters for citrulli-
nated peptide was higher and equal to 52 nm2. These
results suggest that packing densities for phosphorylated
45–89 MBP peptide is higher than for deiminated one. The
association rate coefficient (ka) is derived from the
adsorption energy barrier; thus the higher long-range pro-
tein-membrane repulsion is because of the smaller ka.
Furthermore, we have found that ka for citrullinated 45–89
MBP peptide is smaller than ka for phosphorylated iso-
form, but the desorbability (D) i.e., a coefficient charac-
terizing the dissociation rate of protein from lipids is the
same for both peptides. Thus, comparing the adsorptive
properties of different modified isoforms could be con-
cluded that phosphorylated 45–89 MBP peptides more
efficiently adsorbs on the lipid membrane than citrullinated
Fig. 1 Typical adsorption/desorption kinetics (plots of adsorbed
amount of protein versus time) for phosphorylated (1) and citrulli-
nated (2) MBP peptides. The absorption/desorption kinetics of
phosphorylated (1) and citrullinated (2) MBP peptides (both a bulk
concentrations cb, 20 lg ml
-1) were monitored by optical waveguide
lightmode spectrometry as described in ‘‘Materials and Methods’’.
The arrows mark when the bulk concentration cb was set to zero. The
curve is a representative of three independent experiments
1962 Neurochem Res (2012) 37:1959–1966
123
isoforms and deimination of MBP changes the association/
dissociation parameters of peptide fragments.
Citrullinated MBP 45–89-Induced Cell Death in Mixed
Primary Oligodendrocyte/Microglial Cell Cultures
Since, citrullinated MBP 45–89 peptide fragment could
rapidly dissociate from the myelin sheath into the extra-
cellular fluids and may interact with the various membrane
receptors, in the next series of experiments, the activity of
this peptide was examined. We have found that after
continuous 24 h exposure of mixed oligodendrocyte/
microglial cells to 0.5 lL citrullinated MBP 45–89 only
about 65 % of the cells were still alive (Table 2). Inter-
estingly, the decrease of the viability of cells takes place
only in mixed oligodendrocyte/microglial cultures, but not
in pure cultures of astrocytes, oligodendrocytes or
microglia separately. To examine whether the citrullinated
MBP 45–89-induced cell death has apoptotic features, the
release of mitochondrial cytochrome c into the cytosol was
determined. We isolated the cytosolic fractions from oli-
godendrocyte/microglial cells treated with citrullinated
MBP 45–89 peptide and detected the released cytochrome
c by Western blot analysis. The exposure of oligoden-
drocyte/microglial cells to 0.5 lL citrullinated MBP
45–89 peptide resulted in the release cytochrome c from
mitochondria (Fig. 2A). Thus, citrullinated MBP 45–89
peptide appears to induce cell death mainly through
mitochondrial pathway.
Citrullinated MBP 45–89 Induces Production of NO
and Activation of NF-kB in Microglial Cell Cultures
Nitric oxide, produced by inducible NO synthase (iNOS),
may play a central role in inflammatory demyelinating
disease of the central nervous system. Nitric oxide (NO)
derived from the activation of iNOS in astrocytes and
microglia under the influence of proinflammatory cyto-
kines is presumed to contribute to oligodendrocyte
degeneration in demyelinating diseases [17, 20]. Because
microglia rather than astrocytes are implicated in demye-
linating pathology [21] in the next series of experiments we
examined the effect of citrullinated MBP 45–89 peptide on
the production of NO and activation of NF-kB in microg-
lial cell culture. Figure 2C show that continuous exposure
for 24 h of primary microglial cells to MBP 45–89 peptide
markedly increased production of NO. To understand the
mechanism of this stimulation, we examined the effect of
citrullinated MBP 45–89 on the level of iNOS. Western
blot analysis with antibodies against iNOS clearly shows
that MBP 45–89-mediated nitrite production is engendered
by induction of iNOS (Fig. 2A, line 4). Since the activation
of NF-kB is known to be necessary for the transcription of
iNOS gene in glial cells [22], we examined the effect of
Table 1 Association and dissociation parameters, for the bulk concentration cb = 20 lg ml
-1 of phosphorylated and citrullinated MBP 45–89
peptides
Type of peptides M? (ng/cm
2) a (nm2) Ka (cm s-1 10-5) D
MBP 45–89 peptide from phosphorylated isoform 86 ± 9 17.5 1.4 ± 0.15 5.9 9 10-4 ± 1.3 9 10-4
MBP 45–89 peptide from deiminated isoform 22 ± 8* 52 0.21 ± 0.01* 4.4 9 10-4 ± 2.8 9 10-4
Association and dissociation parameters were analyzed by optical waveguide lightmode spectroscopy as described in ‘‘Materials and Methods’’.
a represent an area occupied by one molecule of peptide; ka is association rate coefficient; M? is total areas occupied by bulk concentration of
peptide; D is the parameter of adhesion strength. The data were normalized to control values from untreated cells. Values represent the
mean ± SEM of three independent determinations performed in duplicate
* P \ 0.05 versus 45–89 MBP peptides from phosphorylated isoform
Table 2 Viability of astrocytes, oligodendrocytes, microglial cells and mixed oligodendrocytes/microglial cells after incubation with citrulli-
nated MBP 45–89 peptides
Conditions % of viability
Astrocytes Oligodendrocytes Microglia Mixed oligodendrocytes and microglia
Cells ? MBP 45–89 peptide 96.7 ± 4.5 87.4 ± 7.2 91.9 ± 7.3 16.4 ± 8.2*
Viability of astrocytes, oligodendrocytes, microglial cells and mixed oligodendrocytes/microglial cells after exposure to 0.5 lM citrullinated
MBP 45–89 for 24 h were assessed by the MTT test as described in ‘‘Materials and Methods’’. The effect of peptide on growth inhibition was
assessed as percentage of cell viability where saline-treated cells were taken as 100 viable. Data are presented as the means ± SEM of three
independent experiments
* P \ 0.05 versus control values (saline-treated cells)
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MBP 45–89 on the activation of NF-kB. For this purpose,
we determined the cytoplasmic levels of the inhibitory IkB
protein after treatment of microglial cells with MBP 45–89.
Western blot analysis with antibody against IkB showed
that MBP 45–89 decreased the level of inhibitory protein
(Fig 2A, line 3). Thus, it could be supposed that secreted
from damaged myelin sheath citrullinated MBP 45–89
induces in the microglial cells degradation of IkB, sub-
sequent nuclear translocation of NF-kB and induction of
the iNOS gene. The resulting elevated concentration of
nitric oxide causes the death of oligodendrocytes.
Discussion
MBP is a major component of the myelin sheath which
interacts with opposed cytoplasmic surfaces of the myelin
membrane and plays an important role in the formation and
maintenance of myelin [10]. Modulated phosphorylation
[23] and citrullination [24, 25] of MBP have been clearly
correlated in demyelinating diseases. The formation of an
abnormal myelin sheath would appear to be an ineluctable
consequence of these modulated modifications. MBP
occurs normally as a number of charge isomers (C1 to C8),
due to phosphorylation, deamidation and deimination. All
of these modifications decrease the net positive charge of
the protein and its ability to cause adhesion of the cyto-
plasmic surfaces of myelin. Reduction in cationicity by
deimination of arginine residues in MBP decreases myelin
compaction and initiates a process that makes myelin
susceptible to degradation. The extent and nature of post-
translational modifications may be related to the extent of
demyelination and disease heterogeneity in multiple scle-
rosis (MS) as suggested by studies of citrullinated MBP.
Kim et al. [23] demonstrated that MS MBP was less
phosphorylated, more methylated, and more deiminated
than MBP from normal tissue. They suggest that multiple
sclerosis may represent a new class of diseases called
‘‘post-translational’’ diseases. Our results agree with this
suggestion because we have found that heavy citrullination
will tend to produce demyelination [5]. Exposure of an
immunodominant epitope in the membrane-bound MBP to
proteases and release of citrullinated encephalitogenic
peptides from protein could induce sensitization of innate
immune-derived cells of the CNS and peripheral T cells
[26]. Thus, electrostatic and hydrophobic interactions
Fig. 2 Citrullinated MBP 45-89 peptide stimulates release of cyto-
chrome c from mitochondria in mixed oligodendrocyte/microglial
cells, induces the expression of iNOS through IkB degradation in
microglial cells and increases the production of NO. A Citrullinated
MBP 45–89 peptide (P 45–89) stimulates release of cytochrome
c from mitochondria in mixed microglia/oligodendrocyte/cells;
western blots, b-actin was used as loading control. B Citrullinated
MBP 45–89 peptide (P 45–89) stimulates degradation of IkB and
induction of iNOS in microglial primary cell cultures; b-actin was
used as loading control; a western blots. Blot is representative of four
similar experiments. b Immunoreactive bands were scanned and the
results are expressed as fold changes versus controls. The average
densitometric quantification of the results of four independent
experiments. Results is presented as mean ± SEM. *P \ 0.05,
compared with controls (saline-treated cells) by one-way ANOVA
followed by the Tukey test. C Citrullinated MBP 45–89 stimulates
production of nitric oxide in primary microglia cells. Microglial cells
were treated with 0.5 lM citrullinated MBP 45–89 (P 45–89) for 24 h
and then the yield of nitrite was measured in the supernatant as
described in ‘‘Materials and Methods’’. Data are means ± SEM of
four independent experiments. *P \ 0.05, compared with controls
(saline-treated cells) by one-way ANOVA followed by the Tukey test
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between MBP and myelin lipids have been shown to be
critical for the formation and stability of the multilamellar
myelin sheath [27–29].
The C-8 component from normal tissue showed increased
citrullination in the arginine residues compared with the
more cationic (phosphorylated) C1-C4 forms. Deimination
in C-8 was found at 43, 49, 54, 65, 97, 122, 130, and 162
arginine residues, three of which (R49, R54, R65) are
localized in peptide 45-89 [23]. These modifications change
the a-helix structure of several peptides of MBP, including
peptide 45–89 and their molar ellipticity is lower than molar
ellipticity of peptides from more cationic isoforms of MBP
[14]. Myelin is enriched in acidic lipids, like glyco-
sphingolipids, galactosylceramide, and its sulfated deriva-
tives. Thus, interaction of various cationic isomers of MBP
and their fragments with acidic lipids is important for elec-
trostatic interactions and stabilization of multilamellar
structure [27]. We have analyzed the adsorption properties of
peptide 45–89 with natural myelin lipids and have found that
citrullinated MBP 45–89 peptide has low adsorption prop-
erties than the same peptide from more cationic (phosphor-
ylated) MBP isoform C3. These data suggest that
citrullinated MBP 45–89 peptides could release and accu-
mulate in the extracellular milieu during myelin sheath
degradation in a higher extent than phosphorylated peptides.
MBP and MBP derived peptides are apparently recog-
nized by a different receptor systems. A major histocom-
patibility complex class II molecule, which is abundantly
expressed in microglia in various neuropathological con-
ditions, is contributed in response to citrullinated peptides
[6]. Besides, these peptides bound with aMb2 integrin [30],
bFGF and ganglioside GM1 receptors [31], cannabinoid
binding sites [32] and membrane actins [33–35]. Our data
shown that citrullinated MBP 45–89 peptide induces NF-
kB activation and iNOS gene expression in microglial
cells, after which the secreted NO could cause the death of
oligodendrocytes.
It has been proposed that some myelin components,
initially released from oligodendrocytes, might activate
microglia, which through proinflammatory cytokines, pro-
duce reactive oxygen species and generate in turn fatal
feedbacks that kill oligodendrocytes [36]. We conclude that
stable immunodominant peptide 45–89 from citrullinated
MBP-C8, through microglial NF-kB activation, iNOS gene
expression and NO production, could induce degradation
of myelin sheet.
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